(3S)-1-Methyl-3-piperidinecarbonitrile | 1217859-44-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (3S)-1-Methyl-3-piperidinecarbonitrile
• 英文别名: (3S)-1-methylpiperidine-3-carbonitrile
• CAS: 1217859-44-3
• 化学式: C₇H₁₂N₂
• 分子量: 124.18
• InChiKey: JYOKDJPITDWCEZ-SSDOTTSWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  27
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF
  申请人：F. Hoffmann-La Roche AG

  公开号：EP3380474B1

  公开（公告）日：2019-08-21
• PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
  申请人：F. Hoffmann-La Roche AG

  公开号：EP3596072B1

  公开（公告）日：2022-06-22
• HETEROCYCLIC COMPOUNDS
  申请人：KYORIN PHARMACEUTICAL CO., LTD.

  公开号：US20170008888A1

  公开（公告）日：2017-01-12

  Provided herein are compounds of formula I and compositions containing the compounds. The compounds and compositions are useful in the methods of inhibiting the action of ERK5, a BET family protein or both. In certain embodiments, the compounds and compositions are useful in the prevention, amelioration or treatment of a ERK5-mediated disease, a BET protein-mediated disease or both.
• [EN] JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF<br/>[FR] INHIBITEURS DES JANUS KINASES, LEURS COMPOSITIONS ET LEUR UTILISATION
  申请人：HOFFMANN LA ROCHE

  公开号：WO2017089390A1

  公开（公告）日：2017-06-01

  Compounds of Formula (00A) and salts thereof, wherein R1, R2 R3, R4 and n are defined herein, are useful as inhibitors of one or more Janus kinases. Also provided are pharmaceutical compositions that include a compound of Formula (00A) and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient. ( 00A)
• [EN] COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS
  申请人：FOGHORN THERAPEUTICS INC

  公开号：WO2020160180A1

  公开（公告）日：2020-08-06

  The present disclosure features compounds useful for the treatment of BAF complex-related disorders.